This UK-based resource supports the monitoring and safe use of anti-tuberculosis drugs and second line treatment of MDR-TB. Its guidance team comprises Jessica L. Potter, Toby Capstick, William M. Ricketts, Nuala Whitehead and Onn Min Kon.
All documents can be found via their website here.
This guideline covers diagnosing, assessing, and treating community-acquired and hospital-acquired...
COPD is the second most common cause for hospital admission and the third leading cause of death...
The Association for Respiratory Technology & Physiology position statement on race-neutral...
The 10-Year NHS Health Plan for England aims to create a new model of care, fit for the future. It...
The National Respiratory Audit Programme (NRAP) clinical audit report - Catching our breath: Time...